Card image cap

Bill Cassidy's Public Statements on Issue: Drugs

Office:
Date Title
09/13/2022 Letter to Social Media CEOs - Hyde-smith, Colleagues Push for Accountability From Social Media Giants for Fentanyl Crisis
04/06/2022 Letter to Rahul Gupta, Director of the Office of National Drug Policy - Cassidy, Burr Urge Biden Administration to Counter Illegal Fentanyl, Support HALT Fentanyl Act
01/20/2022 Letter to Senate Colleagues - Portman, Finance Republicans Stress Innovation-Killing Government Price Control Mandates Must Not Become Law
04/26/2021 Letter to Acting Commissioner Woodcock, FDA - Cassidy, 115 Colleagues Urge FDA to Protect Women and Babies from the Consequences of Chemical Abortions
04/05/2018 Letter to the Honorable Gene Gene Dodaro, GAO Comptroller General - Calls for Review of Federal Anti-Gang Strategy to Combat Opioid Epidemic
03/16/2018 Letter to the Hon. Betsy DeVos, Secretary of Education - Provide Guidance on Most Effective Anti-Opioid Addiction Education
02/16/2018 Letter to the Hon. Robert Patterson, Acting Administrator of the Drug Enforcement Agency - Cassidy, Hassan Seek Answers from DEA Regarding Synthetic Opioid Crackdown
01/04/2018 Letter to the Hon. Gene Dodaro, Comptroller General of the Governmental Accountability Office - Kingpin Act Review
10/03/2017 Letter to the Hon. Don Wright, Acting Secretary of the Department of Health and Human Services - Increase Safeguards Against Opioid Fraud
09/22/2014 Letter to Sylvia Mathews Burwell, Secretary of Health and Human Services - Ensure Access to All Available Addiction Therapies
04/22/2014 Letter to Margaret Hamburg, Commissioner of US Food and Drug Administration - Committee Presses FDA for Documents On Trial Lawyers' Role in Proposed Changes to Generic Drug Labeling
arrow_upward